Apollo ESG NXT System, Apollo REVISE NXT System
K-Number: K232544 · 2023-09-18
Device Summary
Frequently Asked Questions
What is the Apollo ESG NXT System, Apollo REVISE NXT System?
Apollo ESG NXT System, Apollo REVISE NXT System is a medical device that received FDA 510(k) clearance on 2023-09-18. The listed applicant is Apollo Endosurgery, Inc.. The 510(k) number is K232544.
When did Apollo ESG NXT System, Apollo REVISE NXT System receive FDA 510(k) clearance?
Apollo ESG NXT System, Apollo REVISE NXT System received FDA 510(k) clearance on 2023-09-18, under 510(k) number K232544.
Who is the listed applicant for Apollo ESG NXT System, Apollo REVISE NXT System?
The FDA 510(k) record lists Apollo Endosurgery, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Apollo ESG NXT System, Apollo REVISE NXT System?
The FDA product code for Apollo ESG NXT System, Apollo REVISE NXT System is QTD.
Other records listing Apollo Endosurgery, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.